Comments: NJ A973 | 2020-2021 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2020-01-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A973 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A973 at this time.

feedback